This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Demand For Hybrid Solutions To Spur European Interventional Radiology And Cardiology Markets, Finds Frost & Sullivan

LONDON, May 8, 2013 /PRNewswire/ -- The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe. Although the economic slowdown and fewer orders had a negative impact on revenues in 2012, it is expected that expanding applications of interventional systems and the popularisation of hybrid solutions will drive market growth over the 2013-2017 period.

New analysis from Frost & Sullivan ( http://www.medtech.frost.com), Market Trends in Europe Interventional Radiology and Cardiology, finds that the market earned approximately $336.7 million in 2012 and estimates this to reach $352.6 million in 2016. Novel applications, the demand for hybrid solutions and the need for new systems in Eastern Europe will fuel market growth.

One of the key trends in medicine is the steady replacement of open surgeries with minimally invasive procedures. Hybrid operating rooms support this trend.

"The expansion of minimally invasive procedures and hybrid operating rooms are set to galvanise the interventional radiology and cardiology markets," notes Frost & Sullivan's Healthcare Industry Analyst Dominika Grzywinska. "Minimally invasive procedures are becoming increasingly popular, among both patients and healthcare providers. This has spurred the demand for hybrid operating rooms accommodating interventional systems."

Hybrid systems combine operating room equipment with large diagnostic units and can be used by a variety of medical specialties. A mid-term obstacle could potentially be the high cost of such hybrid solutions. Nevertheless, an increasing number of healthcare facilities are investing in such models, as they offer a significant competitive advantage, and with appropriate throughput, a positive return on investment.

The economic slump had a strong impact on revenues in 2012, particularly in the more mature markets of Western Europe, such as Italy and Spain. Confronted by economic uncertainty, many facilities decided to put their investments on hold, contributing to lower revenue generation.

"With approaching market saturation, especially in Western Europe, end users are increasingly interested in user-friendly, integrated solutions," concludes Grzywinska. "Vendors need to offer customised solutions that meet the specific needs of end-users, rather than providing standard, ready-to-use ones."

If you are interested in more information on this research, please send an email to Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Market Trends in Europe Interventional Radiology and Cardiology is part of the Advanced Medical Technologies Growth Partnership Service programme. Frost & Sullivan's related research services include: Medical Imaging Markets in Europe, Image-guided and Robot-assisted Surgery Markets in Western Europe, and Critical Care Solutions in Europe. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs